HOME > News > News >
News
News

Beijing Sciecure Successfully Passing GMP Audit by Teva

Time:2017-09-11 09:17:00   CopyFrom:    Click:

Teva Pharmaceutical Industries, Ltd., world largest generic drug manufacturer, had audited our company from Sept 5 to 8, 2017. During 4 days audit, the auditors had focused on the inspection for small volume parenteral production line etc., as well as the quality system. They were very satisfied all they cheeked and signed the collaboration agreement with our company.

WechatIMG3_compressed.jpg


WechatIMG21_compressed.jpg

Prev:Beijing Sciecure Successfully Passing GMP Audit by MHRA
Next:Marketing Authorization (MA) of Clopidogrel Sciecure 75mg film-coated tablets are granted by UK MHRA

BeiJing Sciecure Pharmaceutical Co. Ltd., Contact info: 010-60447688 Address: Zhongbei Industrial Park, Beishicao Town, Shunyi District, Beijing, China.